226 related articles for article (PubMed ID: 10490817)
1. Caspase-induced proteolysis of the cyclin-dependent kinase inhibitor p27Kip1 mediates its anti-apoptotic activity.
Eymin B; Sordet O; Droin N; Munsch B; Haugg M; Van de Craen M; Vandenabeele P; Solary E
Oncogene; 1999 Aug; 18(34):4839-47. PubMed ID: 10490817
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a p23 caspase-cleaved form of p27[KIP1] involved in G1 growth arrest.
Loubat A; Rochet N; Turchi L; Rezzonico R; Far DF; Auberger P; Rossi B; Ponzio G
Oncogene; 1999 Jun; 18(22):3324-33. PubMed ID: 10362353
[TBL] [Abstract][Full Text] [Related]
3. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade.
Levkau B; Koyama H; Raines EW; Clurman BE; Herren B; Orth K; Roberts JM; Ross R
Mol Cell; 1998 Mar; 1(4):553-63. PubMed ID: 9660939
[TBL] [Abstract][Full Text] [Related]
4. p27KIP1 is down-regulated by two different mechanisms in human lymphoid cells undergoing apoptosis.
Frost V; Sinclair AJ
Oncogene; 2000 Jun; 19(27):3115-20. PubMed ID: 10871865
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
[TBL] [Abstract][Full Text] [Related]
6. Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases.
Sanhes L; Tang R; Delmer A; DeCaprio JA; Ajchenbaum-Cymbalista F
Leukemia; 2003 Jun; 17(6):1104-11. PubMed ID: 12764376
[TBL] [Abstract][Full Text] [Related]
7. Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells.
Kim SG; Kim SN; Jong HS; Kim NK; Hong SH; Kim SJ; Bang YJ
Oncogene; 2001 Mar; 20(10):1254-65. PubMed ID: 11313870
[TBL] [Abstract][Full Text] [Related]
8. Identification of cdk2 binding sites on the p27Kip1 cyclin-dependent kinase inhibitor.
Kwon TK; Nordin AA
Oncogene; 1998 Feb; 16(6):755-62. PubMed ID: 9488039
[TBL] [Abstract][Full Text] [Related]
9. Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts.
An B; Goldfarb RH; Siman R; Dou QP
Cell Death Differ; 1998 Dec; 5(12):1062-75. PubMed ID: 9894613
[TBL] [Abstract][Full Text] [Related]
10. Regulation of p27KIP1 in Epstein-Barr virus-immortalized lymphoblastoid cell lines involves non-apoptotic caspase cleavage.
Frost V; Delikat S; Al-Mehairi S; Sinclair AJ
J Gen Virol; 2001 Dec; 82(Pt 12):3057-3066. PubMed ID: 11714984
[TBL] [Abstract][Full Text] [Related]
11. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
Cereseto A; Washington Parks R; Rivadeneira E; Franchini G
Oncogene; 1999 Apr; 18(15):2441-50. PubMed ID: 10229195
[TBL] [Abstract][Full Text] [Related]
12. Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation.
Baldassarre G; Barone MV; Belletti B; Sandomenico C; Bruni P; Spiezia S; Boccia A; Vento MT; Romano A; Pepe S; Fusco A; Viglietto G
Oncogene; 1999 Nov; 18(46):6241-51. PubMed ID: 10597222
[TBL] [Abstract][Full Text] [Related]
13. p27Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells.
Eymin B; Haugg M; Droin N; Sordet O; Dimanche-Boitrel MT; Solary E
Oncogene; 1999 Feb; 18(7):1411-8. PubMed ID: 10050878
[TBL] [Abstract][Full Text] [Related]
14. Differential modulation of cyclin-dependent kinase inhibitor p27Kip1 by negative signaling via the antigen receptor of B cells and positive signaling via CD40.
Han H; Nomura T; Honjo T; Tsubata T
Eur J Immunol; 1996 Oct; 26(10):2425-32. PubMed ID: 8898956
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex.
Russo AA; Jeffrey PD; Patten AK; Massagué J; Pavletich NP
Nature; 1996 Jul; 382(6589):325-31. PubMed ID: 8684460
[TBL] [Abstract][Full Text] [Related]
16. Increased cdc2 and cdk2 kinase activity by retinoid X receptor gamma-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines.
Crowe DL; Shuler CF
Cell Growth Differ; 1998 Aug; 9(8):619-27. PubMed ID: 9716179
[TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibitors abolish cell death downstream of caspase activation during anti-microtubule drug-induced apoptosis in leukemia cells.
Nagy K; Petak I; Imre G; Barna G; Gezane-Csorba M; Sebestyen A; Houghton JA; Mihalik R; Kopper L
Anticancer Res; 2005; 25(5):3321-6. PubMed ID: 16101145
[TBL] [Abstract][Full Text] [Related]
18. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
Tsihlias J; Zhang W; Bhattacharya N; Flanagan M; Klotz L; Slingerland J
Oncogene; 2000 Feb; 19(5):670-9. PubMed ID: 10698512
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
[TBL] [Abstract][Full Text] [Related]
20. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes.
Ravanko K; Järvinen K; Paasinen-Sohns A; Hölttä E
Cancer Res; 2000 Sep; 60(18):5244-53. PubMed ID: 11016654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
